VG290131
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VG290131, covering 2024-07-26 to 2024-07-26. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of Single and Multiple Doses of VG290131 in Healthy Subjects [Phase 1]